Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 259 (RN7SKP259) is annotated as a non-coding RNA pseudogene found on chromosome 11 (chr11:57451690-57452022, hg38)[2]. Pseudogenes like RN7SKP259 are typically defective copies of functional RNA genes—in this case, the 7SK small nuclear RNA gene. The functional 7SK RNA is an essential component of the 7SK ribonucleoprotein complex, which regulates RNA polymerase II transcription elongation by sequestering positive transcription elongation factor b (P-TEFb)[1]. However, RN7SKP259 lacks evidence of transcription or functional RNA production, does not participate in ribonucleoprotein complexes, and has no recorded biological or disease role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 259 (RN7SKP259).